As part of lifecycle management, ICH guidance recommends identifying and evaluating opportunities to improve drug safety and continually expand the body of knowledge in the manufacturing of drug products. In this study, we demonstrate increased recovery and sensitivity for quality indicating attributes in a RPLC peptide mapping assay using an LC and column engineered with modified bioinert hardware while preserving compatibility with legacy methods to facilitate easier method migration.
Title | Format | File Size |
---|---|---|
Download PDF | 995.86kB |